NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spineart

Spineart

Private
Plan-les-OuatesHealthcare & Life Scienceshttps://www.spineart.com/

Last Round

Early Funding

Sep 26, 2025

Est. Valuation

$224.8M

Total Funding Raised

$139.6M

Company Overview

Spineart is a medical device company that designs, develops, and markets innovative solutions for spine surgery, including minimally invasive implants, motion preservation devices, and robotic navigation technologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

spinal implantssurgical instrumentationspine surgeryspinal fusionmedtechpedicle screw systemneurosurgeryorthopedic surgerysurgical roboticsrobotic navigationinterbody systemsbone cementannular closureambulatory surgery centersASC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spineart Comps

Public and private peers based on sector, stage, and business model.

Spineart comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Spineart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 26, 2025
Convertible DebtMar 18, 2024
Growth EquityJun 5, 2020
Growth EquitySep 20, 2016

Key People

Founding team and executive leadership

Jerome Levieux

CEO

Executive Team

Jerome Trividic

Chief Executive Officer

Executive Team

Laurent Node-Langlois

Chief Technology Officer

Executive Team

Guillaume Amblard

Chief Product Officer

Executive Team

Spineart Investors

Notable investors and investment history

Spineart investors
InvestorRounds
GimvGrowth Equity, Early Funding
EGS Beteiligungen AGEarly Funding, Growth Equity

Spineart Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spineart Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spineart's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlan-les-Ouates
Employee Range345
Year Founded2005
Last FundingSep 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.